Back
Day Range
$15.68
$18.71
52-Week Range
$2.88
$24.00
Volume
853,969
50D / 200D Avg
$20.04
/
$10.02
Prev Close
$18.63
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -7.2 | 0.3 |
| P/B | 2.1 | 2.9 |
| ROE % | -27.1 | 3.7 |
| Net Margin % | -896.1 | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$42.50
+163.8%
Low: $23.00
High: $62.00
Forward EPS
-$2.76
Est. Revenue
71 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
-$3.59
-$3.59 – -$3.59
|
1.5 M | 1 |
| FY2028 |
-$3.07
-$3.52 – -$2.59
|
1 M | 3 |
| FY2027 |
-$2.73
-$3.81 – -$0.24
|
20 M | 5 |
Key Takeaways
Debt/Equity of 0.02 — conservative balance sheet
Negative free cash flow of -82.35M
PEG of 0.09 suggests growth is underpriced
Capital efficient — spends only 7.99% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-27.09%
ROIC-25.07%
Net Margin-896.11%
Op. Margin-1031.46%
Safety
Debt / Equity
0.02
Current Ratio14.24
Interest Coverage133.11
Valuation
P/E Ratio
-7.17
P/B Ratio2.12
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 9.00M | Net Income (TTM) | -80.61M |
| ROE | -27.09% | ROA | -27.33% |
| Gross Margin | 0.00% | Operating Margin | -1031.46% |
| Net Margin | -896.11% | Free Cash Flow (TTM) | -82.35M |
| ROIC | -25.07% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.02 | Current Ratio | 14.24 |
| Interest Coverage | 133.11 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -7.17 | P/B Ratio | 2.12 |
| P/S Ratio | 64.22 | PEG Ratio | 0.09 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 577.62M | Enterprise Value | 394.30M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 9.00M | 0.0 | 0.0 | 0.0 |
| Net Income | -80.61M | -71.11M | -63.85M | -39.72M |
| EPS (Diluted) | -2.24 | -6.63 | -8.55 | -5.32 |
| Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -92.78M | -78.19M | -48.40M | -39.97M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 294.89M | 358.23M | 25.92M | 28.43M |
| Total Liabilities | 22.84M | 35.11M | 199.32M | 140.99M |
| Shareholders' Equity | 272.05M | 323.13M | -173.40M | -112.56M |
| Total Debt | 5.56M | 8.70M | 53.25M | 2.47M |
| Cash & Equivalents | 188.89M | 354.35M | 21.64M | 27.64M |
| Current Assets | 286.79M | 357.10M | 25.31M | 28.03M |
| Current Liabilities | 20.14M | 27.78M | 58.17M | 5.86M |